Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 11, 2011, Pages 1556-1559

  Qazi, Fahad ^a   Khan, U ^a   Khowaja, S ^a   Javaid, M ^b   Ahmed, A ^b   Salahuddin, N ^b   Hussain, H ^a   Becerra, M C ^c   Golub, J E ^d   Khan, A J ^a  

^a Maternal and Child Health   (Pakistan)

^b THE INDUS HOSPITAL   (Pakistan)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Culture conversion; Drug resistant TB; MDR TB; Pakistan

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN; PYRAZINAMIDE; PYRIDOXINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DELAYED DIAGNOSIS; DRUG EFFECT; FEMALE; HEALTH PROGRAM; HUMAN; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PAKISTAN; PATIENT COUNSELING; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; SPUTUM CULTURE;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; DIRECTLY OBSERVED THERAPY; DRUG MONITORING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; SPUTUM; TIME FACTORS; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 80053975879     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0679     Document Type: Article

References (9)

1. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/ 2008.402. Geneva, Switzerland: WHO, 2008.
2. Gopi P G, Chandrasekaran V, Subramani R, et al. Association of conversion and cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen. Ind J Med Res 2006; 123: 807-814. (Pubitemid 44269948)
3. Singla R, Osman M M, Khan N, Al-Sharif N, Al-Sayegh M O, Shaikh M A. Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis 2003; 7: 58-64. (Pubitemid 36427032)
4. Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan P J, McAdam K P. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia. Int J Tuberc Lung Dis 1998; 2: 712-718. (Pubitemid 28429720)
5. World Health Organization. Anti-tuberculosis drug resistance inthe world. 4th global report. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
6. Laserson K F, Thorpe L E, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 640-645. (Pubitemid 40826156)
7. Holtz T H, Sternberg M, Kammerer S, et al. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med 2006; 144: 650-659. (Pubitemid 46780649)
8. Heller T, Lessells R J, Wallrauch C G, et al. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu- Natal, South Africa. Int J Tuberc Lung Dis 2010; 14: 420-426.
9. Katiyar S K, Bihari S, Prakash S, Mamtani M, Kulkarni H. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2008; 12: 139-145. (Pubitemid 351212404)